Home › Left Ventricular Dysfunction › New York › New York City
Left Ventricular Dysfunction clinical trials in New York City, NY
4 studies for Left Ventricular Dysfunction are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingPhase 2/3
- Columbia University Medical Center-Pediatric Cardiology ( Site 0016), New York
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RecruitingObservational studyHealthy volunteers welcome
- Mount Sinai Hospital, New York
Left Ventricular Dysfunction trials in other cities
- Cleveland, OH4 studies
- The Bronx, NY3 studies
- Aurora, CO3 studies
- Houston, TX3 studies
- St. Louis, MO3 studies
- Boston, MA3 studies
- Philadelphia, PA3 studies
- Cincinnati, OH3 studies
- Pittsburgh, PA3 studies
- Atlanta, GA3 studies
- Ann Arbor, MI3 studies
- Dallas, TX3 studies
Other studies in New York City
- Breast Cancer134 studies
- Non-Small Cell Lung Cancer120 studies
- Cancer (all types)110 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer77 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Pancreatic Cancer60 studies
- Multiple Myeloma60 studies
- Endometrial Cancer52 studies
- Heart Failure51 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.